首页> 外文期刊>European Journal of Pharmacology: An International Journal >Vasoconstrictor 5-HT receptors in the smooth muscle of the rat middle cerebral artery
【24h】

Vasoconstrictor 5-HT receptors in the smooth muscle of the rat middle cerebral artery

机译:大鼠大脑中动脉平滑肌中的血管收缩剂5-HT受体

获取原文
获取原文并翻译 | 示例
           

摘要

Serotonin (5-HT) can constrict cerebral arteries via activation of 5-HT 1B and 5-HT 2A receptors. Our goal was to reveal the importance and relative contribution of the two 5-HT receptor subtypes to the serotonin-induced vasoconstriction in the rat middle cerebral artery. The vasoconstrictor effects of 5-carboxamidotryptamine, sumatriptan and 5-HT were measured without and with pre-treatment with SB 216641 (5-HT 1B antagonist), or ritanserin, (5-HT 2A antagonist), in endothelium-denuded arteries, in vitro. All agonists caused vasoconstrictions. The order of potency (EC 50) of the compounds was: 5-carboxamidotryptamine (14±3 nM)5-HT (270±30 nM)sumatriptan (5.8±1.9 μM). The concentration-response curve of 5-carboxamidotryptamine resembled the sum of two sigmoid curves (EC 50 14±3 nM and 15±7 μM), and SB 216641 and ritanserin antagonized its low and high concentration components, respectively. Vasoconstrictions evoked by 5-HT at low and high concentrations were also fully antagonized by SB 216641 and ritanserin, respectively. Sumatriptan constricted the middle cerebral artery exclusively via 5-HT 1B receptors. The efficacy of 5-carboxamidotryptamine and sumatriptan was low in comparison to the maximum contractile force elicited by 120 mmol/l KCl, reaching only 18-23% for 5-HT 1B and 14% for 5-HT 2A receptor activation. In conclusion, 5-HT produced small vasoconstrictions in the rat middle cerebral artery that were mediated by 5-HT 1B receptors with high potency and by 5-HT 2A receptors with low potency. Thus, 5-HT may have a minor physiological role in blood flow regulation via 5-HT 1B receptor activation while 5-HT 2A receptors seem to have a pathophysiological role in this vessel.
机译:5-羟色胺(5-HT)可以通过激活5-HT 1B和5-HT 2A受体来收缩脑动脉。我们的目标是揭示两种5-HT受体亚型对大鼠大脑中动脉中5-羟色胺诱导的血管收缩的重要性和相对贡献。在不使用SB 216641(5-HT 1B拮抗剂)或利坦色林(5-HT 2A拮抗剂)的情况下,在内皮剥除的动脉中,测量5-羧酰胺基色胺,舒马曲坦和5-HT的血管收缩作用。体外。所有激动剂引起血管收缩。化合物的效力顺序(EC 50)为:5-羧酰胺基色胺(14±3 nM)> 5-HT(270±30 nM)>苏马曲普坦(5.8±1.9μM)。 5-羧酰胺基色胺的浓度-响应曲线类似于两条乙状结肠曲线的总和(EC 50 14±3 nM和15±7μM),SB 216641和利坦色林分别拮抗其低浓度和高浓度成分。 5-HT在低浓度和高浓度引起的血管收缩也分别被SB 216641和利坦色林完全拮抗。苏门曲普坦仅通过5-HT 1B受体收缩大脑中动脉。与120 mmol / l KCl引起的最大收缩力相比,5-羧酰胺基色胺和舒马曲坦的功效较低,5-HT 1B的活化仅达到18-23%,5-HT 2A受体的活化仅达到14%。总之,5-HT在大鼠中脑动脉中产生小的血管收缩,这是由高效的5-HT 1B受体和低效的5-HT 2A受体介导的。因此,5-HT通过5-HT 1B受体激活在血流调节中可能具有较小的生理作用,而5-HT 2A受体似乎在该血管中具有病理生理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号